BiotechTube
Home/Daxor/Jonathan Feldschuh
JF

Jonathan Feldschuh

Chief Scientific Officer

Daxor

Therapeutic Areas

CardiovascularCritical Care

Daxor Pipeline

DrugIndicationPhase
BVA for Heart Failure ManagementHeart Failure (HFpEF/HFrEF)Commercial
BVA for Critical Care/ICUSepsis, Septic Shock, ARDSCommercial
BVA for Surgical Blood LossPerioperative & Surgical SettingsCommercial
BVA for SyncopeUnexplained SyncopeCommercial
BVA for Cardiorenal SyndromeHeart Failure with Renal DysfunctionResearch

Leadership Team at Daxor

MF
Michael Feldschuh
President and Chief Executive Officer
RJ
Robert J. Michel
Chief Financial Officer
View full Daxor profile